Skip to content

FOXO4-DRI: Benefits & Research

Part of the FOXO4-DRI Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Selective Senescent Cell Clearance

FOXO4-DRI selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction that keeps these cells alive. In the original 2017 study, treatment restored fitness, fur density, and renal function in naturally aged mice — demonstrating that clearing senescent cells can reverse functional aging.

Aging Phenotype Reversal

Treated mice showed restored liver and kidney function, improved coat condition, and increased activity levels. Chemotherapy-damaged mice showed faster recovery when treated with FOXO4-DRI, suggesting accelerated clearance of therapy-induced senescent cells.

Cellular Selectivity

FOXO4-DRI's mechanism is inherently selective — it only disrupts FOXO4-p53 interactions active in senescent cells. Non-senescent cells do not rely on this interaction for survival and are therefore spared. This selectivity distinguishes FOXO4-DRI from less targeted senolytics.

Frequently Asked Questions

References

  1. Baar MP, et al.. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell, 2017.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.